Clinical Study gynecology

Patient testimonials

par Marc Antoine Aimé | Oct 13, 2026 | Clinical Study gynecology

Patient testimonials GYNECOLOGY Lichen Sclerosus | Vaginal Dryness ; 3 How do patients describe the evolution of their symptoms and quality of life after PRP treatment? 2 Patient testimonial01 / 04 Vaginal Dryness · Lichen Sclerosus “Little by little, I...

Expert insights

par Marc Antoine Aimé | Oct 9, 2026 | Clinical Study gynecology

Expert insights GYNECOLOGY Lichen Sclerosus | Vaginal Dryness ;  Expert insightsGYNECOLOGYDr. Vanessa Rabeau-ConriGynecologic Oncologic SurgeonPresident, VIVMED“Quality of life is an integral part of care.”01Why is it important to address women's intimate...

Autologous platelet rich plasma (A-PRP) combined with pelvic floor muscle training for the treatment of female stress urinary incontinence (SUI): A randomized control

par Marc Antoine Aimé | Oct 2, 2026 | Clinical Study gynecology

Stress urinary incontinence Saraluck 2023 Autologous platelet rich plasma (A-PRP) combined with pelvic floor muscle training for the treatment of female stress urinary incontinence (SUI): A randomized control clinical trial. Clinical evidence · Gynaecology There is...

Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomized controlled study

par Marc Antoine Aimé | Oct 2, 2026 | Clinical Study gynecology

Postmenopausal vulvovaginal atrophy Hamid 2025 Value of injection of plasma-rich platelets in the vaginal mucosa in cases with vulvovaginal atrophy: a prospective double-blinded randomized controlled study. Clinical evidence · Gynaecology There is growing interest in...

FEMALE SEXUAL DYSFUNCTION | Runels 2014

par Marc Antoine Aimé | Mar 3, 2025 | Clinical Study gynecology

FEMALE SEXUAL DYSFUNCTION Runels 2014 A Pilot Study of the Effect of Localized Injections of Autologous Platelet Rich Plasma (PRP) for the Treatment of Female Sexual Dysfunction. Female sexual dysfunction may be manifested by decreases in sexual desire, arousal and...

STRESS URINARY INCONTINENCE | Long 2021

par Marc Antoine Aimé | Fév 17, 2025 | Clinical Study gynecology

STRESS URINARY INCONTINENCE Long 2021 A pilot study: effectiveness of local injection of autologous platelet-rich plasma in treating women with stress urinary incontinence. Stress urinary incontinence (SUI) is usually the result of the weakening of, or damage to, the...



RegenPRP™

RegenPRP™ is a medical treatment that uses platelet-rich plasma from the patient's own blood to enhance and tissue regeneration.



RegenPRP™ - HA

RegenPRP™ - HA combination is an innovative treatment combining platelet-rich plasma (PRP) and hyaluronic acid to improve tissue regeneration and healing.

CM-OA

CM-Skin



RegenPRP™ - ATS

RegenPRP™ combined with ATS (Autologous Thrombin Serum) is an advanced approach to tissue regeneration that uses autologous thrombin-enriched platelet-rich plasma (PRP) to maximise healing effects.



RegenExtracell®

RegenExtracell is an innovative tissue regeneration treatment using an extracellular matrix enriched with platelet-rich plasma (PRP).



RegenWound

RegenWound is a fully autologous solution prepared from the patient’s own blood, with the objective of providing a standardised and reproducible approach for clinical use.



Regulatory

Manufacturers of medical devices based outside the EU must designate an Authorized Representative (EU-REP) established within the EU in order to meet the CE requirements for placing medical devices on the EU market.



Quality Management

Regen Lab Quality System Management ensures the consistency of our products quality in total GMP compliance.

Our production facility rooms atmosphere is monitored to satisfy non-pyrogenic medical devices manufacturing.



Patents

As a leader in the PRP&HA regenerative field and as an innovation-driven company, Regen Lab SA has devoted important resources since 2004 to put on the market pioneering and diversified products constituting a complete set of tools/technologies for the medical community.